Figure 2.
Aberrant m6A regulator and global m6A levels in drug-resistant cancer. The changes in m6A levels and the expression of m6A regulators were present after chemotherapy and targeted drug treatment in multiple cancer. BC, breast cancer; CSCC, cervical squamous cell carcinoma; CRC, colon cancer; GC, gastric cancer; HCC, hepatocellular carcinoma; NPC, nasopharyngeal carcinoma; NSCLC, non-small cell lung cancer; OSCC, oral squamous cell carcinoma; OS, osteosarcoma; OC, ovarian cancer; PC, pancreatic cancer.
